Download 1. Author/Instructor Information

COPE Submission Form
1. Author/Instructor Information
X
Include Most Current CV for each
Lead Author/Instructor Name: Michael D. DePaolis, O.D.
Address: 169 Rue DeVille
Rochester NY, 14618-2633
Author/Instructor OE Tracker Number:
Please confirm your profile is updated with COPE.
Link: http://www.arbo.org/cope_course_qualification.html
2. Disclosure of Financial/Proprietary Interests
Please identify any direct financial or proprietary interests you may have in any of
the companies, products, pharmaceuticals or services you may have mentioned, or
intend to mention, in your presentation. You must also disclose if you provide forprofit support of any kind, are a paid consultant to, an employee of, or serve as an
officer on the board of any companies mentioned in your presentation. Should
your course be approved, this information must also be disclosed at the beginning
of your presentation to your audience in a clear and unambiguous manner, both
verbally, and included in your written course handout/outline.
Please mark n/a if there is nothing to disclose.
Manufacturer or Service Provider
Nature of Relationship (e.g., employee, consultant,
research grant recipient, speakers bureau, stockholder,
etc.)
Slack, Inc, Optometric Editor,
Primary Care Optometry News
RevitalVision
Bausch & Lomb
Salary
Independent Board Member
Speaker’s Bureau
3. Content
X
X
X
COPE Planning Form
Page 1 of 4
Include article or slides (print or live)
Multiple-choice quiz and answer key for quiz (print only)
Clinical photos with identifying captions and figures/tables/charts (print
only)
COPE Submission Form
4. Objectives--Please list the objectives here 3-5 required
 Define ocular surface health and its overall role in optimizing vision and
eye comfort.
 Identify the clinical and environmental factors which may adversely
impact ocular surface health.
 Discuss available research findings that quantify the changes to the ocular
surface caused by chronic exposure to eyedrop preservatives.
 Explain how strategies that improve the ocular surface can favorably
benefit patient adherence to antiglaucoma pharmacotherapy.
5. Course Description--Please describe the course in 35 words or less:
Ocular surface disease (OSD) affects about 15% of people age 65 and over and
can be complicated by the use of glaucoma medications. The symptoms of ocular
surface disease can affect the vision and the quality of life (QOL) of patients with
glaucoma and can result in their noncompliance with glaucoma therapy.
Optometrists who treat patients with glaucoma must be aware of the symptoms
and causes of ocular surface disease, the potential effect of preservatives in some
glaucoma medications on development of the disease, and strategies to manage
concomitant ocular surface disease and glaucoma in their patients.
Vindico Medical Education assembled a panel of experts to discuss the
management of coexisting glaucoma and ocular surface disease. The experts
reviewed the definition of a healthy ocular surface, considered effective
diagnostic tools and treatment options for ocular surface disease, and discussed
the potential effects of antiglaucoma medications and their preservatives on the
ocular surface. The panel highlighted diagnostic strategies, evaluated methods to
control ocular surface disease while managing glaucoma, and offered their
insights regarding choosing medications that are either preservative-free or
contain “soft” preservatives.
6. Detailed Course Outline--Insert below or attach
Ocular Surface Health
Medications and the Eye
Impact of the Compromised Ocular Surface on Glaucoma
Improving Clinical Practice
7. Using the categories below, please select which describes this program:
GL
Contact Lenses (CL) All aspects of contact lens therapy inclusive of keratoconus and postsurgical
treatments.
Functional Vision/Pediatrics (FV) Those portions of optometric practice that deal with visual processing and neuro-optometric
rehabilitation, including sports vision; binocular vision; and visual training or vision development courses.
General Optometry (GO) Any study in the area of the eye and vision care, which constitutes eye
COPE Planning Form
Page 2 of 4
COPE Submission Form
and vision research, or examination, diagnosis and treatment of anomalies of the human eye and visual system. For the purposes of
these categories .General Optometry. excludes any other category enumerated here.
Low Vision (LV) All aspects of low vision devices, care and therapy.
Glaucoma (GL) The study of the etiology, clinical pathophysiology, diagnosis, treatment, management, and the outcomes of
therapeutic regimens for the ocular condition involving the relationship of intraocular pressure and abnormal optic nerve function.
Examples: Any course with major emphasis on diagnosis, treatment, and/or surgical and medical management, of glaucoma (i.e.,
trabeculectomy, laser surgery for glaucoma).
Peri-Operative Management of Ophthalmic Surgery (PO)The study and clinical training of any ophthalmic surgical procedure of
the eye and adnexa (not to include any other procedures covered in other categories). Examples: Includes all aspects of pre- and postoperative management of ocular surgery care (excluding Refractive Surgery), i.e., cataract, lid surgery/procedures, strabismus
surgery, keratoplasty, etc.
Refractive Surgery Management (RS) Instruction and/or clinical training in refractive or photorefractive technologies, which may
include Peri-operative Patient Management: Counseling and evaluation for indications or contraindications in patient selection,
including recognition of associated complications and course of action in analysis and treatment. Examples: Courses related
specifically to management of PRK, RK and LASIK patients; corneal refractive surgery, etc.
Treatment & Management of Ocular Disease: Anterior Segment (AS)The study of the etiology, clinical pathophysiology,
diagnosis, treatment, management, and outcomes of therapeutic regimens for anomalies of the anterior segment of the human eye.
Examples: Keratitis, anterior uveitis, conjunctivitis, blepharitis, lid anomalies, foreign body removal, etc.
Treatment & Management of Ocular Disease: Posterior Segment (PS) The study of the etiology, clinical pathophysiology,
diagnosis, treatment, management, and outcomes of therapeutic regimens for anomalies of the posterior segment of the human eye.
Examples: Degenerative, infective, and vascular diseases of the retina/choroid/sclera and optic nerve, inclusive of all aspects of
surgical care involving the posterior segment of the eye, i.e., retinopathies, neuropathies, retinal laser surgery, retinal detachment
surgery, etc.
Neuro-Optometry (NO) The study of the etiology, clinical evaluation, diagnosis, treatment and management of disease and disorders
of the nervous system, both systemically, and as it relates directly to the eye and visual system. Examples: Includes all aspects of
nervous system conditions involving the brain, cranial nerves, spinal cord, peripheral nerves, and corresponding muscles, i.e.,
multiple sclerosis, pituitary tumor, brain trauma, Myasthenia Gravis, papilledema, Horner’s Syndrome, etc.
Pharmacology (PH) The study of the interaction of chemical agents with biological systems. Examples: Toxicology; adverse effects
of systemic drugs; adverse effects of ocular drugs; control of ocular pain. Any courses related to medications and how they affect the
various tissues or their mechanism of actions.
Principles of Diagnosis (PD) The study of the art and science of the process of determining the nature and circumstances of a
diseased condition with emphasis on the biological and clinical procedures utilized in medical examination and disease differentiation,
and underlying clinical pathophysiology, e.g., corneal topography, visual fields (unless specific to glaucoma); laboratory testing and
imaging; fluorescein angiography; gonioscopy.
Systemic/Ocular Disease (SD) The study of the relationship of any anomaly of normal function of the human body and the possible
manifestation of such as signs and/or symptoms in the eye or visual system. Examples: General study of diabetes, HIV/AIDS, thyroid
disease, etc., along with their ocular manifestations. Vascular diseases both systemic and ocular.
Ethics/Jurisprudence (EJ) The study of body of law and ethics in the practice of optometry and its relationship to the
medicolegal system. Example: Any courses related to rules and practice acts for optometry or addressing medico legal
issues related to patient treatment, judicious prescribing, medical errors and other liability concerns and issues.
Practice Management (PM) The study of management of the affairs of optometric practice. This
does not include courses that are intended strictly for personal enhancement, business development,
or investment prowess. Examples: Concepts in managed care and operations management; courses designed to help market practices;
educate and/or manage office staff; improve fiscal efficiency; billing and coding, clinical record keeping, etc.
8. Attestation:
I have submitted this information to the best of my knowledge. I understand that
Vindico Medical Education will be submitting this information and the article to
COPE for approval on my behalf.
COPE Planning Form
Page 3 of 4
COPE Submission Form
____ Michael D. DePaolis, O.D.______ ____
Signature (electronic or typed)
COPE Planning Form
Page 4 of 4
1/3/2012____
Date